The physiological effects of cocaine are mediated by inhibition of dopamine reuptake, and subsequent enhancement of dopaminergic neurotransmission. We have recently made a surprising and unexpected finding that physiological effects of cocaine in animals require methylation of adenosine residues in mRNA. Adenosine methylation was discovered last year, and constitutes the first, and potentially only, reversible mRNA modification. Our group showed that methylation of adenosine residues in mRNA to form N6- methyladenosine (m6A) is highly prevalent and affects over 8,000 transcripts in the brain. Furthermore, adenosine methylation and demethylation is regulated by signaling pathways, suggesting that adenosine methylation, like protein phosphorylation, may be a fundamental mechanism mediating effects of signaling pathways in cells. The goal of this application is to substantially advance our understanding of this newly discovered and largely mysterious mRNA modification that appears to have a central role in synaptic transmission. As part of our overall goal to understand the cellular functions of m6A and to determine how it regulates dopaminergic neurotransmission, the specific aims of this proposal are: (1) To map m6A sites in the midbrain transcriptome at single-nucleotide resolution. We will develop a next-generation sequencing approach that incorporates a novel chemical biology strategy to label m6A in living cells. These experiments will provide new insights into the potential biological functions of m6A and will result in the identification of m6A sites in the midbrain transcriptome for analysis and mutagenesis in Aims 2 and 3;(2) To determine how FTO affects the translation of its target mRNAs. The mechanism by which mRNAs are translationally suppressed by m6A is not known. In this aim, we will address the potential molecular pathways by which m6A influence mRNA fate in cells. (3) To identify the FTO targets that is required for cocaine signaling in dopaminergic neurons. Here we will test FTO-target mRNAs that influence neurotransmission and synaptic signaling for their ability to rescue the impaired cocaine effects in FTO-/- slices. These experiments will elucidate the first signaling pathway linking methylation of specific mRNAs to physiological changes in neurons. The experiments proposed here will begin to decipher the role of a novel, highly prevalent, and medically important mRNA modification that is poised to have important roles in dopamine neurotransmission as well as other signaling pathways in neurons and other tissues.

Public Health Relevance

We recently discovered that adenosine methylation is the first, and possibly only, highly prevalent and reversible modification in mRNA. We recently found that animals that exhibit high levels of adenosine methylation in specific mRNAs in the midbrain are nearly resistant to the motor and synaptic signaling effects of cocaine, identifying adenosine methylation as a central regulator of dopaminergic neurotransmission. In this application, we propose experiments to uncover how adenosine methylation controls the effects of cocaine by: (1) developing novel techniques for precisely localizing the residues that are methylated at a transcriptome-wide level;(2) by determining how methylated adenosine affects mRNA stability and translation;and (3) by identifying the FTO-regulated mRNAs that control dopaminergic signaling.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-MXL-F (08))
Program Officer
Satterlee, John S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Schools of Medicine
New York
United States
Zip Code
Meyer, Kate D; Jaffrey, Samie R (2014) The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol 15:313-26